Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) Pfizer Inc

6th May 2014 11:40

RNS Number : 3377G
Morgan Stanley Capital Services LLC
06 May 2014
 



 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

05 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 328,258

 30.7500 USD

 29.8600 USD

 COMMON STOCK

 SALES

 745,160

 30.7500 USD

 29.8500 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 26

 29.8700 USD

 COMMON STOCK

 CFD

 LONG

 4

 29.8700 USD

 COMMON STOCK

 CFD

 LONG

 21,567

 29.9340 USD

 COMMON STOCK

 CFD

 LONG

 162,760

 29.9342 USD

 COMMON STOCK

 CFD

 LONG

 2

 29.9600 USD

 COMMON STOCK

 CFD

 LONG

 12

 29.9600 USD

 COMMON STOCK

 CFD

 LONG

 137,500

 29.9600 USD

 COMMON STOCK

 CFD

 LONG

 1,600

 29.9693 USD

 COMMON STOCK

 CFD

 LONG

 2,300

 29.9952 USD

 COMMON STOCK

 CFD

 LONG

 4,600

 29.9963 USD

 COMMON STOCK

 CFD

 LONG

 7,300

 29.9971 USD

 COMMON STOCK

 CFD

 LONG

 7,700

 30.0000 USD

 COMMON STOCK

 CFD

 LONG

 62,743

 30.0052 USD

 COMMON STOCK

 CFD

 LONG

 3,700

 30.0077 USD

 COMMON STOCK

 CFD

 LONG

 136,610

 30.0121 USD

 COMMON STOCK

 CFD

 LONG

 8,700

 30.0374 USD

 COMMON STOCK

 CFD

 LONG

 18,200

 30.0398 USD

 COMMON STOCK

 CFD

 LONG

 111,800

 30.0398 USD

 COMMON STOCK

 CFD

 LONG

 21,645

 30.0509 USD

 COMMON STOCK

 CFD

 LONG

 200

 30.0900 USD

 COMMON STOCK

 CFD

 LONG

 200

 30.1350 USD

 COMMON STOCK

 CFD

 SHORT

 304

 29.8600 USD

 COMMON STOCK

 CFD

 SHORT

 48

 29.8600 USD

 COMMON STOCK

 CFD

 SHORT

 4,200

 29.8712 USD

 COMMON STOCK

 CFD

 SHORT

 24,400

 29.8949 USD

 COMMON STOCK

 CFD

 SHORT

 1,900

 29.9179 USD

 COMMON STOCK

 CFD

 SHORT

 592

 29.9500 USD

 COMMON STOCK

 CFD

 SHORT

 4,000

 29.9500 USD

 COMMON STOCK

 CFD

 SHORT

 10,900

 29.9503 USD

 COMMON STOCK

 CFD

 SHORT

 22,852

 29.9508 USD

 COMMON STOCK

 CFD

 SHORT

 9,371

 29.9513 USD

 COMMON STOCK

 CFD

 SHORT

 12,366

 29.9521 USD

 COMMON STOCK

 CFD

 SHORT

 3,882

 29.9521 USD

 COMMON STOCK

 CFD

 SHORT

 2,776

 29.9662 USD

 COMMON STOCK

 CFD

 SHORT

 204

 29.9772 USD

 COMMON STOCK

 CFD

 SHORT

 19

 29.9772 USD

 COMMON STOCK

 CFD

 SHORT

 18,176

 30.0126 USD

 COMMON STOCK

 CFD

 SHORT

 3,525

 30.0162 USD

 COMMON STOCK

 CFD

 SHORT

 24,000

 30.0162 USD

 COMMON STOCK

 CFD

 SHORT

 19,900

 30.0228 USD

 COMMON STOCK

 CFD

 SHORT

 1,600

 30.0235 USD

 COMMON STOCK

 CFD

 SHORT

 24,700

 30.0580 USD

 COMMON STOCK

 CFD

 SHORT

 14,298

 30.0600 USD

 COMMON STOCK

 CFD

 SHORT

 300

 30.0700 USD

 COMMON STOCK

 CFD

 SHORT

 1,300

 30.0873 USD

 COMMON STOCK

 CFD

 SHORT

 7,800

 30.2400 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

06 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBGGDURXGBGSL

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,711.37
Change31.08